NEURO62

Presentation information

Print

Oral Session

[O-46] Oral Session 46 Clinical trial and Regenerative medicine3

Sat. May 22, 2021 10:15 AM - 11:45 AM Room 10 (ICC Kyoto 1F Swan Hall)

Chair：Abe Koji(Department of Neurology, Okayama University)

[O-46-4] Phase 3 Study of Galcanezumab in Patients with Treatment-Resistant Migraine: Japanese Sub-Population

○Yasuhiko Matsumori1, Tomomi Nakamura2, Akichika Ozeki2, Holland C. Detke3 (1.Sendai Headache and Neurology Clinic, Japan, 2.Eli Lilly Japan K.K., 3.Eli Lilly and Company)

Abstract password authentication.
Password is written on a pocket program and name badge.

Password